Mark Hahn

2020 - Verona Pharma plc

In 2020, Mark Hahn earned a total compensation of $18.5M as Chief Financial Officer at Verona Pharma plc.

Compensation breakdown

Non-Equity Incentive Plan$275,000
Salary$229,167
Stock Awards$17,915,584
Other$35,047
Total$18,454,798

Hahn received $17.9M in stock awards, accounting for 97% of the total pay in 2020.

Hahn also received $275K in non-equity incentive plan, $229.2K in salary and $35K in other compensation.

Rankings

In 2020, Mark Hahn's compensation ranked 262nd out of 13,090 executives tracked by ExecPay. In other words, Hahn earned more than 98.0% of executives.

ClassificationRankingPercentile
All
262
out of 13,090
98th
Division
Manufacturing
79
out of 5,621
99th
Major group
Chemicals And Allied Products
23
out of 2,254
99th
Industry group
Drugs
21
out of 1,954
99th
Industry
Pharmaceutical Preparations
12
out of 1,459
99th
Source: SEC filing on March 19, 2021.

Hahn's colleagues

We found three more compensation records of executives who worked with Mark Hahn at Verona Pharma plc in 2020.

2020

David Zaccardelli

Verona Pharma plc

Chief Executive Officer

2020

Kathleen Rickard

Verona Pharma plc

Chief Medical Officer

2020

Jan-Anders Karlsson

Verona Pharma plc

Chief Executive Officer

News

You may also like